PLRX logo

Pliant Therapeutics, Inc.

PLRX
Healthcare|Biotechnology|US
$0.81
-0.01 (-0.75%)
DCF Value
$0.27
Tangible Book / Share
$2.37
Cash / Share
$2.55
Next Earnings Report
Mar 17, 2027
EPS est. -$0.37 · Revenue est. $3.8M
Financing Filings (last 12 months)
1
Shelf registrations / offering prospectuses — latest Mar 30, 2026 (S-3). Possible dilution.

Upcoming Data Readouts (1)

Jun 2030
Est. completion
P1Advanced or Metastatic Solid Tumor
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
NCT06270706n=124

Recent Press Releases

Pliant Therapeutics Announces Presentations at the 2026 Annual Meeting of the Society for Immunotherapy of Cancer
Oct 29, 2026 · GlobeNewsWire
Pliant Therapeutics Appoints Craig Blanchette, Ph.D., as Senior Vice President, Research (siRNA)
Oct 20, 2026 · GlobeNewsWire
Pliant Therapeutics Announces Upcoming Presentation at European Society for Medical Oncology Congress 2026
Oct 19, 2026 · GlobeNewsWire
Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
Sep 30, 2026 · GlobeNewsWire
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-101095 in Combination with Pembrolizumab for the Treatment of ICI-Refractory Solid Tumors
Aug 18, 2026 · GlobeNewsWire
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2026 Financial Results
Aug 11, 2026 · GlobeNewsWire

SEC Filings (65)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Aug 14, 2026SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Aug 11, 20268-KMaterial eventDocumentIndex
Aug 11, 202610-QQuarterly reportDocumentIndex
Jul 13, 20268-KMaterial eventDocumentIndex
Jun 11, 20268-KMaterial eventDocumentIndex
May 11, 202610-QQuarterly reportDocumentIndex
May 11, 20268-KMaterial eventDocumentIndex
Apr 22, 2026ARSAnnual report to holdersDocumentIndex
Apr 22, 2026DEFA14AProxy / shareholder voteDocumentIndex
Apr 22, 2026DEF 14AProxy / shareholder voteDocumentIndex
Apr 17, 20268-KMaterial eventDocumentIndex
Apr 6, 2026EFFECTDocumentIndex
Mar 30, 2026S-3Shelf registrationDocumentIndex
Mar 30, 20268-KMaterial eventDocumentIndex
Mar 11, 2026S-8Employee stock planDocumentIndex
Mar 11, 20268-KMaterial eventDocumentIndex
Mar 11, 202610-KAnnual reportDocumentIndex
Mar 3, 20268-KMaterial eventDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 17, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 9, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 30, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 22, 2026SC 13GPassive 5%+ stakeDocumentIndex
Jan 8, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Dec 16, 20258-KMaterial eventDocumentIndex
Dec 8, 20258-KMaterial eventDocumentIndex
Nov 14, 2025SC 13GPassive 5%+ stakeDocumentIndex
Nov 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Nov 6, 202510-QQuarterly reportDocumentIndex
Nov 6, 20258-KMaterial eventDocumentIndex
Oct 24, 20258-KMaterial eventDocumentIndex
Oct 20, 20258-KMaterial eventDocumentIndex
Sep 4, 2025SC 13GPassive 5%+ stakeDocumentIndex
Aug 14, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Aug 7, 202510-QQuarterly reportDocumentIndex
Aug 7, 20258-KMaterial eventDocumentIndex
Aug 6, 2025SC 13GPassive 5%+ stakeDocumentIndex
Jul 29, 2025SC 13G/APassive 5%+ stakeDocumentIndex
Jul 17, 2025SC 13G/APassive 5%+ stakeDocumentIndex